US Hereditary Angioedema Association Medical Advisory Board 2013 Recommendations for the Management of Hereditary Angioedema Due to C1 Inhibitor Deficiency

Bruce L. Zuraw, Aleena Banerji, Jonathan A. Bernstein, Paula J. Busse, Sandra C. Christiansen, Mark Davis-Lorton, Michael M. Frank, Henry H. Li, William R. Lumry, Marc Riedl

Research output: Contribution to journalArticle

Abstract

Background: The treatment of hereditary angioedema (HAE) has undergone dramatic changes as newer medicines have become available in recent years. Optimal care of these patients requires a comprehensive management plan. Although several consensus papers have been published concerning the diagnosis and treatment of HAE, guidelines for a comprehensive management plan have not been developed. Objective: To develop state-of-the-art recommendations for the treatment and management of HAE due to C1 inhibitor (C1INH) deficiency in the United States. Methods: Members of the US Hereditary Angioedema Association Medical Advisory Board began by reviewing the literature concerning treatment of HAE. Preliminary recommendations were developed based on the literature review, discussions in a face-to-face meeting, and refinements in a series of drafts. Final recommendations reflect the unanimous consensus of the medical advisory board and the US Hereditary Angioedema Association leadership. Results: Recommendations are provided regarding a comprehensive care plan for HAE, including the following: development of an overall management plan, treatment of angioedema attacks, prophylactic treatment, and patient monitoring. Conclusion: A comprehensive individualized management plan developed between an expert HAE physician and the patient, in collaboration with local medical providers and emergency departments, can provide patients with the best opportunity to lead a normal life.

Original languageEnglish (US)
Pages (from-to)458-467
Number of pages10
JournalJournal of Allergy and Clinical Immunology: In Practice
Volume1
Issue number5
DOIs
StatePublished - Sep 2013
Externally publishedYes

Keywords

  • Bradykinin
  • C1 inhibitor
  • Hereditary angioedema
  • Management
  • On-demand treatment
  • Prophylactic treatment

ASJC Scopus subject areas

  • Immunology and Allergy

Fingerprint Dive into the research topics of 'US Hereditary Angioedema Association Medical Advisory Board 2013 Recommendations for the Management of Hereditary Angioedema Due to C1 Inhibitor Deficiency'. Together they form a unique fingerprint.

  • Cite this